This is the authors' abstract. We don't add key points for this paper.
Surgical decompression of the portal system by construction of an anastomosis between the splenic and left renal veins or between the portal vein and inferior vena cava is an effective treatment for portal hypertension in cirrhosis.Shunts of this type have been shown to be remarkably effective in the prevention of recurrent variceal bleeding (1, 2).In view of the known high incidence of repeated and eventually fatal hemorrhages in those cirrhotics who have already had one episode of variceal bleeding, there is little question concern- ing the indication for a shunt in such patients, providing they have sufficient hepatic reserve to withstand the immediate trauma of surgery.With improvement in surgical technique and patient selection, the previously formidable mor- tality from these operations has been greatly re- duced.Consideration can now be given to ex- tending the indication for shunt surgery to patients with demonstrable varices which have not yet ruptured (3).In debating the merits of "pro- phylactic shunts," we need both statistics concern- ing the life expectancy and probability of variceal rupture in these patients under conservative ther- apy, and information concerning the changes in hepatic hemodynamics and metabolism that might result from the various shunting procedures.The available data bearing on the latter problem are limited and are concerned largely with the changes after splenorenal shunt.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Redeker et al. (1958) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: